NEW YORK, Oct. 26 Reportlinker.com announces that a new market research report is available in its catalogue. Ion channels represent a significant opportunity to address an underexploited class of ...

LONDON, March 11, 2025 (GLOBE NEWSWIRE) -- Kaerus Bioscience (www.kaerusbio.com), a clinical-stage biopharmaceutical company created by Medicxi for the development of therapeutics for rare genetic ...

CHARLOTTESVILLE, Va. & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Cavion, Inc., a clinical stage biotechnology company developing novel therapeutics for neurological diseases, announced today that their first ...

The What Else: Channel Vision’s new 2-Channel, 1080p HDMI Modulator has a full set of features, including the full spectrum of TV channels on ATSC-antenna and QAM-64/256 for cable TV systems, MPEG, ...

Ion channel are essential pore forming membrane proteins whereby some drugs may interact directly or indirectly that leads to change in electric signals and action potential across the membrane. Ion ...

U.K. company will exploit discovery platform to identify candidates against a specific target. U.K. firm Xention and Germany-based pain therapeutics specialist Grünenthal have established a research ...

Reportlinker.com announces that a new market research report is available in its catalogue: Global Ion Channel Modulators Industry http://www.reportlinker.com ...

LONDON, July 25, 2024 (GLOBE NEWSWIRE) -- Kaerus Bioscience Ltd. (www.kaerusbio.com), a clinical-stage biotechnology company focused on developing therapeutics for rare genetic syndromes of ...